Patent Overview: Developments in H. pylori Research

References to primary literature

• MARSHALLB J, ARMSTRONJGA, MCGECHIE postulates for pyloric campylobacter. Med. DB, GLANCYR J: Attempt to fulfill Koch�s .IA.u s~.(I 985) 142:439–444.
   Google Scholar
• BIZZOZERO G: Über die schlauchformigen Driisen des Magendarmkanals und die Beziehungen ihres Epithels zu dem Ober-flachenepithel der Schleimhaut. Arch. f mikr. Anat. (1893) 42:82–152.
   Google Scholar
• TYTGAT GNJ, AXON ATR, DIXON MF, GRAHAM DY, LEEA, MARSHALL BJ: Helicobacter py-lori: Causal agent in peptic ulcer disease? Working Party Report of the World Congress of Gastroenterology, 26–31 August 1990, Sydney, Australia. Blackwell Scientific Publications.
   Google Scholar
• LEE A: Helicobacter pylori: Causal agent in peptic ulcer. Microbiological aspects. J. Gas-troenterol. Hepatol. (1991) 6:115–120.
   PubMed Web of Science ®Google Scholar
• MOBLEY HLT, Hu LT, FOXALL PA: Helicobac-ter pylori urease: properties and role in pathogenesis. Scand. J. Gastroenterol. (1991) 26 Suppl. 187:39–46.
   Google Scholar
• NEWELL DG: Virulence factors of Helicobac-ter pylori. Scand. J. Gastroenterol. (1991) 26 (Suppl. 187): 31–38.
   Google Scholar
• HEATLEY RV: Helicobacter infection and in-flammation. Scand.Gastroenterol. (1991)26 (Suppl. 187):23–30.
   Google Scholar
• BLASER MJ: Hypotheses on the pathogenesis and natural history of Helicobacter pylori - induced inflammation. Gastroenterol. (1992) 102:720–727.
   PubMed Web of Science ®Google Scholar
• TYTGAT GNJ, NOACH L, RAUWS EAJ: He-licobacter pylori. Scand.Gastroenterol.(1991) 26 (Suppl. 187):1–8.
   Google Scholar
• Moss S, CALAM J: Helicobacter pylori and peptic ulcers: the present position. Gut (1992) 33:289–292.
   PubMed Web of Science ®Google Scholar
• WYATT H, RATHBONE BJ, HEATLEY RV: Local immune response to gastric Campylobacter in non-ulcer dyspepsia-1. Clin. Pathol. (1986) 39:863–870.
   PubMed Web of Science ®Google Scholar
• SIPPONEN P, VARIS K, FRAKI 0, KORRI UM, SEPPALA K, SIURALA M: Cumulative 10-year risk of symptomatic duodenal and gastric ul-cer in patients with or without chronic gas-tritis. Scand. J. Gastroenterol. (1990) 25:966–973.
   PubMed Web of Science ®Google Scholar
• SIPPONEN P, KEKKI M, SIURALA M: The Syd-ney system: epidemiology and natural his-tory of chronic gastritis. J. Gastroenterol. Hepatol. (1991) 6:244–251.
   PubMed Web of Science ®Google Scholar
• PARSONNET J, FRIEDMAN GD, DANIEL MS, VANDERSTEEN P, CHANG Y, VOGELMAN JH, ORENTEICH N, SIBLEY RK:Helicobacter py-lori: infection and the risk of gastric car-cinoma. New Engl. J. Med. (1991) 325:1127–1131.
   PubMed Web of Science ®Google Scholar
• NOMURA A, STEMMERMAN GN, CHYOU PH, KATO I, PEREZ-PEREZ GI, BLASER MJ: Heli-cobacter pylori infection and gastric carci-noma among Japanese Americans in Hawaii. New Engl. .1. Med. (1991) 325:1132–1136.
   Google Scholar
• SIPPONEN P, KOSUMEN TU, VALLE J, RIIHELA M, SEPPALA K: Helicobacter infection and chronic gastritis in gastric cancer. J. Clin. Pathol. (1992) 45:319–323.
   PubMed Web of Science ®Google Scholar
• Fox JG, CORREA P, TAYLOR NS, THOMPSON N, FONTHAM E, JANNEY F, SOBHAN M, RUIZ B, HUNTER F: High prevalence and persis-tence of cytotoxin-positive Helicobacter py-lori strains in a population with high preva-lence of atrophic gastritis. Am. J. Gastroen-terol. (1992) 87:1554–1560.
   PubMedGoogle Scholar
• RAUWS EAJ, LANGENBERG A, HOUTHOFF HJ, ZANEN HC, TTGAT GNJ: Campylobacter pyloridis-associated chronic active gastritis. A prospective study of its prevalence and the effects of antibacterial and anti ulcer treat-ment. Gastroenterol. (1988) 94:33–40.
   Google Scholar
• MORRIS AJ, ALI MR, NICHOLSON GI, PEREZ-PEREZ GI, MI: Long-term follow-up of vol-untary ingestion of Helicobacter pylori. Ann. Intern. Med. (1991) 114:662–663.
   PubMed Web of Science ®Google Scholar
• Di NAPOLI A, PETIUNO R, BOERO M, BELLIS D, CHIANDUSSI L: Quantative assessment of histological changes in chronic gastritis after eradication of Helicobacter pylori. J. Clin. Pathol. (1992) 45:796–798.
   PubMed Web of Science ®Google Scholar
• RAUWS EM, TYTGAT GNJ: Cure of duode-nal ulcer associated with eradication of He-licobacter pylori. Lancet (1990) 335:1233–1235.
   PubMedGoogle Scholar
• AXON ATR: V. Helicobacter pylori therapy: Effect on peptic ulcer disease. J. Gastroen-terol. Hepatol. (1991) 6:131–137.
   Google Scholar
• GRAHAM DY, LEW GM, EVANS DG, EVANS DJ, KLEIN PD: Effect of triple therapy (anti-biotic plus bismuth) on duodenal ulcer heal-ing. Ann. Intern. Med. (1991) 115:266–269.
   PubMed Web of Science ®Google Scholar
• GRAHAM DY, LEW GM, KLEIN PD, EVANS DG, EVANS DJ, SAEED ZA, MALATY HM: Ef-fect of treatment of Helicobacter pylori in-fection on the long-term recurrence of gas-tric or duodenal ulcer. Ann. Intern. Med. (1992) 116:705–708.
   PubMed Web of Science ®Google Scholar
• HENTSCHEL E, BRANDSTATTER G, DRAGOSICS B, HIRSCHL AM, NEMEC H, SCHUTZE K, TAUFFER M, WORZER H: Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. New Engl. J. Med. (1993) 328:308–312.
   PubMed Web of Science ®Google Scholar
• GLUPCZYNSKI Y, BURETTE A, LABBE M, DEPREZ C, DE REUCK M, DELTENRE M: Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxicillin. Am. J. Gastroenterol. (1988) 83:365–372.
   PubMed Web of Science ®Google Scholar
• PATEY 0, CHAPLAIN C, DLTBLANCHET A, MALKIN JE, ROUCAYROL AM, CHARASZ N: Failure of treatment with metronidazole for Campylobacter pylori: infection. In: Gastro-duodenal pathology and Campylobacter pylori: " Megraud F and Lamouilatte H Eds. (1989) pp 629–632 (Elsevier Science Publishers).
   Google Scholar
• GLUPCZYNSKI Y, BURR1E A: Drug therapy for Helicobacter pylori infection: problems and pitfalls. Am. J. Gastroenterol. (1990) 85:1545–1551.
   PubMed Web of Science ®Google Scholar
• MARSHALL BJ: The use of bismuth in gas-troenterology. Am. J. Gastroenterol. (1991) 86:16–25.
   PubMed Web of Science ®Google Scholar
• CHIBA N, ROA By, RADEMAKER JVV, HUNT RH: Meta-analysis of the efficacy of anti-biotic therapy in eradicating Helicobacter pylori. Am. 1 Gastroenterol (1992) 87:1716–1727.
   Google Scholar
• HENTSCHEL E, HIRSCHL AM, SCHÜTZE K, DUFEK W: Amoxicillin and metronidazole in the eradication of Campylobacter Klin. Wochenschr (1989) 65 (Suppl XVIH):29.
   Google Scholar
• O'RIORDAN T, MATHAI E, TOBIN E, MCKENNA D, KEANE C, SWEENEY E, O'MORAIN C: Ad-juvant antibiotic therapy in duodenal ul-cers treated with colloidal bismuth subci-trate. Gut (1990) 31:999–1002.
   PubMed Web of Science ®Google Scholar
• BELL GD, WEIL J, POWELL K, JOBSON R, HARRISON G, GANT PW, JONES PH, OWEN RI, MORENO M, TROWELL JE: Helicobacter py-lori: treated with combinations of tripotas-sium dicitrato and metronidazole: efficacy of different treatment regimens and some ob-servations on the emergence of metronida-zole resistance. Eur. Gastroenterol. Hepatol. (1991) 3:819–822.
   Web of Science ®Google Scholar
• LABENZ J, GYENES E, Rem. GH, BORSCH G: Combined amoxycillin/omeprazole treat-ment (two weeks) for eradication of Heli-cobacter pylori. Ital. J. Gastroenterol. (1991) 23 (Suppl. 2):108–109.
   Google Scholar
• BAYERDGREFER E, MANNES G, SOMIvIER A, HGCHTER W, WEINGARAT J, HATZ R, MIEHLKE S, LEHN N, RUCICDESCHEL G, DIRSCHEDL P, STOLTE M: Longterm follow-up after Hell-cobacter pylori: eradication with combined omeprazole and amoxicillin treatment. Irish J. Med. Sci. (1992) 161 (Suppl 10):89–90.
   Google Scholar
• LOGAN RPH, GUMMETT PA, HEGARTY BT, WALKER MM, BARON JH, MISIEWICZ JJ: Clar-ithromycin and omeprazole for Helicobacter pylori. Lancet (1992) 340:239.
   PubMedGoogle Scholar
• DE KOSTER E, NYST JF, DEPREZ C, GLUPCZYN-SKI Y, JONAS C, DENIS P, VAN GEEL J, BUSET M, DE REUCK M, DELTENRE M: Hp treatment: Disappointing results with amoxicillin plus omeprazole. Ital. J. Gastroenterol. (1991) 23 (Suppl. 2):105.
   Google Scholar
• BELL GD, POWELL K, WEIL J, BURRIDGE SM, MORDEN A, HARRISON G, GANT PW, JoNEs PH, TROWELL JE: Experience with omepra-zole in combination with either amoxy-cillin or colloidal bismuth subcitrate in patients with metronidazole-resistant Heli-cobacter pylori. Eur. J. Gastroenterol. Hepa-tol. (1991) 3:923–926.
   Web of Science ®Google Scholar
• LOGAN RPH, Rusto MA, GUMMETT PA, HEGARTY B, WALKER MM, BARON JH, MIKE-WICZ JJ: Omeprazole and amoxycillin sus-pension for Helicobacter pylori. Irish J. Med. Sci. (1992) 161 (Suppl. 10):16.
   Google Scholar
• COLLINS R, BEATTIE S, O'MORAIN C: High dose omeprazole plus amoxycillin in the treatment of acute duodenal ulcer. Irish J. Med. Sci. (1992) 161 (Suppl. 10):96–97.
   Google Scholar
• LOGAN RPH, GummErr PA, MISIEWICZ JJ, KARim QN, WALKER MM, BARON JH: One week eradication regimen for Helicobacter pylori. Lancet (1991) 338:1249–1252.
   PubMedGoogle Scholar
• PATCHET S, BEATTIE S, KEANE C, O'MORAIN C: Short report: short-term triple ther-apy for H. pylori-associated duodenal ulcer disease. Aliment. Pharmacol. Therap. (1992) 6:113–117.
   Google Scholar
• NOACH LA, LANGENBERG ML, BERTOLA MA, DANKERT J, TYTGAT GNJ: Impact of metron-idazole resistance on the eradication of He-licobacter pylori. Ph.D. thesis LA Noach (1993).
   Google Scholar
• MARSHALL BJ, WARREN JR, FRANCIS GJ, LANGTON SR, GOODWIN CS, BLINCOW ED: Rapid urease test in the management of Campylobacter pyloridis-associated gastri-tis. Am. J. Gastroenterol. (1987) 82:200–210.
   PubMed Web of Science ®Google Scholar
• HAZELL SL, BORODY TJ, GAL A, LEE A: Campylobacter pyloridis gastritis I: detec-tion of urease as a marker of bacterial colo-nization and gastritis. Am. J. Gastroenterol. (1987) 82:292–296.
   PubMed Web of Science ®Google Scholar
• BORSCH G, OPFERKUCH W: Schnelltest ffir Campylobacter pylori. Dtsch. Med. Wochen-
   Google Scholar
• WARRELMANN M, HAHN H, MENGE H, SCHMIDT H: Campylobacter pylori: Nachweisverfahren. Dtsch. Med. Wochenschr (1987) 112:821–822.
   PubMedGoogle Scholar
• BAYERDERR E, SOMMER A, OTTENIANN R, Campylobacter pylori. Dtsch. Med Wochen-schr (1987) 112:902–903.
   PubMedGoogle Scholar
• ARVIND AS, COOK RS, TABAQCHALI S. FARTH-ING MJG: One-minute endoscopy room test for Campylobacter pylon. Lancet (1988) 1: 704.
   Google Scholar
• WEBER J, ASTHEIMER W, RIEMANN JF, NAGEL D: Ammoniakbestimmung in nuchtern Ma-gensaft. Dtsch. Med. Wochenschr. (1988) 113:76–77.
   Google Scholar
• GOGGIN PM, METHA AJ, FINCH PJ, CORBISHLEY CM, NORTHFIELD TC: Gastric juice urea as a diagnostic test for Helicobacter pylori infection. Rev. ESP. En$ Digest. (1990) 87 (suppl. 1): 14–15.
   Google Scholar
• TRIEBLING AT, KORS'TEN MA, DLuGosz JW, PARONE~FO, L IEBERC S: Severity of Helicobacter-induced gastric injury correlates with gastric juice ammonia. Dig. Dis. Sci. (1991) 8:1089–1096.
   Google Scholar
• WESTBLOM TU: Laboratory diagnosis and handling of Helicobacter pylori. In: Heli-cobacter pylori in peptic ulceration and gastritis: Marshall BJ, Mc Callum RW, Guerrant RL, eds. (1991) pp 81–91 (Blackwell Scientific Publications).
   Google Scholar
• ANSORG R, VON RECICLINGHAUSEN G, POMARIUS R, SCHMIDE N: Evaluation of techniques for isolation, subcultivation and preservation of Helicobacter pylon. J. Clin. Microbiol. (1991) 29:51–53.
   PubMedGoogle Scholar
• WESTBLOM TU, MADAN E, MIDKIFF BR: Egg yolk emulsion agar, a new medium for the cultivation of Helicobacter pylori. J. Clin. MicrobioL (1991) 29:819–821.
   PubMedGoogle Scholar
• ENGSTRANDL, PAHLSONC, SCHWAN A, GUSTAVSSOSN: Monoclonal antibodies for detection of Campylobacter pylori in biopsy smears and frozen sections. Scand. J. Gastroenterol. (1988) 23 (Suppl. 142):50–52.
   Google Scholar
• HUSSON MO, LECLERC H: Detection of He-licobacter pylori in stomach tissue by use of a monoclonal antibody. J. Clin. Microbiol. (1991) 29:2831–2834.
   PubMedGoogle Scholar
• RIVERA E, LOPEZ-VIDAL Y, LUGUESIO V, RUIZ-PALACIOS G: Indirect immunofluorescence assay for detection of Helicobacter pylori in human gastric mucosal biopsies. J. Clin. Mi-crobioL (1991) 29:1748–1751.
   PubMedGoogle Scholar
• ENGSTRAND L, PALSON C, MATTSON J, JOHANS-SON KE: The specificity of a synthetic oligonucleotide DNA. Probe for detection of Helicobacter pylori. Rev. Esp. Enf Digest. (1990) 78 (Suppl. 1):28–29.
   Google Scholar
• VALENTINE JL, ARTHUR RR, MOBLEY HLT, DICK JD: Detection of Helicobacter pylori by using the polymerase chain reaction. J. Clin. Microbiol. (1991) 29:689–695.
   PubMed Web of Science ®Google Scholar
• CLAYTON C. KLEANTHOUS K, TABAQCHALI S: Detection and identification of Helicobacter pylori by the polymerase chain reaction. J. Clin. Pathol. (1991) 44:515–516.
   PubMed Web of Science ®Google Scholar
• BIRAC C, TALL F, ALBENQUE M, LABIGNE A, MEGRAUD F: PCR to detect Helicobacter py-lori in the mouth. Irish J. Med. Sci. (1992) 161 (Suppl. 10):28.
   Google Scholar
• MAPSTONE NP, LYNCH DAF, AXON ATR, DIXON MF, QUIRKE P: The detection of Heli-cobacter pylori in faeces by the polymerase chain reaction. Irish J. Med. Sci. (1992) 161 (Suppl. 10):29.
   Google Scholar
• VELDHUYZEN VAN ZANTEN SJO, TYTGAT KMAJ, HOLLINGSWORTH J, JALALI S, RASHID FA, BOWEN BM, GOLDM J, GOODACRE RL, RIDDELL RH, HUNT RH: 14C-urea breath test for the detection of Helicobacter pylori. Am. Gastroenterol. (1990) 85:399–403.
   PubMedGoogle Scholar
• HUSEBYE E, O'LEARY D, SICAR V. MELBY K: How reliable are the 14C-urea breath test and specific serology for the detection of gas-tric Campylobacter? Scand. J. GastroenteroL (1991) 25:725–730.
   Google Scholar
• DILL S. PAYNE-JAMES JJ, MISIEWICZ JJ, GRIMBLE GK, MC SWIGGAN D, PATHAK K, WOOD AJ, SCRIMGEOUR CM, RENNIE MI: Evaluation of 13C-urea breath test in the de-tection of Helicobacter pylori and in moni-toring the effect of tripotassium dicitratobis-muthate in non-ulcer dyspepsia. Gut (1990) 31:1237–1241.
   PubMedGoogle Scholar
• NEWELL DG, HAw'riN PR, STACEY AR, MCDOUGALL MH, RUDDLE AC: Estimation of the prevalence of Helicobacter pylori infec-tion in an asymptomatic elderly population comparing breath test and serology. J. Clin. PathoL (1991) 44:385–387.
   PubMedGoogle Scholar
• GRAHAM DY, KLEIN PD, EVANS DG, EVANS DJ, ALPERT LC, OPEKUN A, JERDACK GR, MORGAN DR: Simple noninvasive method to test efficacy of drugs in the eradication of Helicobacter pylori infection: the example of combined bismuthsubsalicylate and nitrofu-rantoin. Am. J. Gastroenterol. (1991) 86:1158–1162.
   PubMed Web of Science ®Google Scholar
• LAMBERT JR, HANSKY J, DAVIDSON A, PINKARD K, STOCKMAN K: Campylobacter like organ-isms (CLO)-in vivo and in vitro susceptibil-ity to antimicrobial and antiulcer therapy. Gastroenterol. (1985) 88:1462.
   Google Scholar
• TYTGAT GNJ, LANGENBERG ML, RAUWS E, RIETRA PJGM: Campylobacter like organism (CLO) in the human stomach. Gastroenterol. (1985) 88:1620.
   Google Scholar
• LEE F1, SAMLOFF LM, HARDMAN M: Compar-ison of tri-potassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers. Lancet (1985) 1:1299–1301.
   PubMedGoogle Scholar
• MOSHAL MG, GREGORY MA, PILLAY C, SPITAELS JM: Does the duodenal cell ever return to normal? A comparison between treatment with cimetidine and De-Nol. Scand. J. Gastroenterol. (1979) 14 (Suppl. 54):48–51.
   Google Scholar
• ANONYMUS: Ulcer study no threat to ulcer drug firms. Marketletter, February 22, 1993.
   Google Scholar
• LOGAN RPH, GREAVES RR, GUMMETT PA, WALKER MM, KARIM QN, DUGGAN AE, BARON JH, MistEwicz JJ: The in-vivo effect of ranitidine bismuth citrate on H. pylori. Irish J. Med. Sci. (1992) 161 (Suppl. 10):94.
   Google Scholar
• Loo VG, SHERMAN P, MATLOW AG: Heli-cobacter pylori infection in a pediatric popu-lation: in vitro susceptibilities to omeprazole and eight antimicrobial agents. Antimicrob. Agents Chemother. (1992) 36:1133–1135.
   PubMedGoogle Scholar
• MEGRAUD F, BOYANOVA L, LAMOULIA1-1h, H: Activity of lansoprazole against Helicobacter pylori. Lancet (1991) 337:1486.
   PubMed Web of Science ®Google Scholar
• IwAlil T, SATOH H, NA1CAO M, IWASAK/ T, YAMAZAKI T, KUBO K, TAMURA T, IMADA A: Lansoprazole, a novel benzimidazole proton pump inhibitor and its related compounds have selective activity against Helicobacter pylori. Antimicrob. Agents Chemother. (1991) 35:490–496.
   PubMedGoogle Scholar
• LAMOULIATTE H, BERNARD PH, CAYLA R, VAILETTE G, QUINTON A, MEGRAUD F, LEMA1RE M: Effect of lansoprazole against Heli-cobacter pylori in vivo. Gastroenterol. (1992) 102:A106.
   Google Scholar
• CZINN Si, NEDRUD JG: Oral immunization against Helicobacter pylori. Infect. Immun. (1991) 59:2359–2363.
   PubMed Web of Science ®Google Scholar
• CHEN M, LEE A, HAZELL S: Immunisation with Helicobacter. The first evidence for pro-tection against gastric infection. Irish J. Med. Sci. (1992) 161 (Suppl. 10):29.
   Google Scholar
• EATON KA, BROOKS AL, MORGAN DR, KRA-KOWKA S: Essential role of urease in patho-genesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect. Immun. (1991) 59:2470–2475.
   PubMed Web of Science ®Google Scholar
• GOLDLE J, VELDHUYZEN VAN ZANTEN SJO, JALALI S. RICHARDSON H, HUNT RH: In-hibition of urease activity but not growth of Helicobacter pylori by acetohydroxamic acid. J. Clin. PathoL (1991) 44:695–697.
   PubMedGoogle Scholar
• EL NUJUMI AM, DORRIAN CA, CHITTAJALLU RS, NEITHERCUT WD, McCoLL KEL: Effect of Helicobacter pylori urease activity by ace-tohydroxamic acid on serum gastrin in duo-denal ulcer subjects. Gut (1991) 32:866–870.
   PubMed Web of Science ®Google Scholar
• ZHENG ZT, WANG ZY, CHU YX, LI YN, LI QF,LIN SR, Xu ZM: Double-blind short-term trial of furazolidone in peptic ulcer. Lancet (1985) 1:1048–1049.
   PubMedGoogle Scholar
• MORGAN D, KRAFT W, BENDER A, PEARSON A: Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. Gas-troenterol. (1988) 95:1178–1184.
   PubMed Web of Science ®Google Scholar
• COELHO LGV, PASSOS MCF, CHAUSSON Y, COSTA EL, MAIA AF, BRANDAO MJCC, RODRIGUES DC, CASTRO LP: Duodenal ulcer and eradication of Helicobacter pylori in a developing country. Scand. J. Gastroenterol. (1992) 27:362–366.
   PubMedGoogle Scholar